The deal gives Research Dynamics the necessary springboard as a technology CRO, to bring cost savings to sponsors for clinical trials. Financial terms of the deal were not disclosed.
Research Dynamics provides management services for clinical trials, specifically in the areas of Oncology, MS and Alzheimer Disease, which will now have the option of utilising VirtualScopics' biomarker imaging technology.
VirtualScopics' algorithms enable three-dimensional registration, fusion, hard and soft tissue identification, anatomically guided segmentation and feature extraction.
Sponsors can determine the efficacy of a compound earlier in the clinical trial process.
In addition, an improvement in image analysis throughput is possible by eliminating "reader" bottleneck via automation.
Sample size requirements can be reduced through increased precision while a compressed trial time yields longer patent protected revenue streams.
These applications comply with applicable regulatory requirements (CFR21 Pt. 11) for FDA-facing trials, or can be designed specifically for a particular study per sponsor requirements.